Zeige Ergebnisse 161 - 170 von 218
2007
Hasler M, Vonk R, Hothorn LA. Assessing non-inferiority of a new treatment in a three-arm trial in the presence of heteroscedasticity. Statistics in medicine. 2007 Sep 12;27(4):490-503. doi: 10.1002/sim.3052
Hothorn LA, Neuhäuser M, Koch HF. Analysis of randomized dose-finding-studies: Closure test modifications based on multiple contrast tests. Biometrical journal. 2007 Jan 18;39(4):467-479. Epub 2007 Jan 18. doi: 10.1002/bimj.4710390408
Hothorn LA. How to deal with multiple treatment or dose groups in randomized clinical trials? Fundamental and Clinical Pharmacology. 2007 Feb 7;21(2):137-154. doi: 10.1111/j.1472-8206.2007.00469.x
Hothorn LA. Multiple comparisons and multiple contrasts in randomized dose-response trials: Confidence interval oriented approaches. Journal of Biopharmaceutical Statistics. 2007 Feb 2;16(5):711-731. Epub 2007 Feb 2. doi: 10.1080/10543400600860576
Schaarschmidt F. Experimental design for one-sided confidence intervals or hypothesis tests in binomial group testing. Communications in Biometry and Crop Science. 2007;2(1):32-40.
Toschki A, Hothorn LA, Roß-Nickoll M. Effects of cultivation of genetically modified Bt maize on epigeic arthropods (Araneae; Carabidae). Environmental entomology. 2007 Aug;36(4):967-981. doi: 10.1603/0046-225X(2007)36[967:EOCOGM]2.0.CO;2
2006
Dilba G, Bretz F, Hothorn LA, Guiard V. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins. Statistics in medicine. 2006 Okt 11;25(7):1131-1147. doi: 10.1002/sim.2359
Eckert J, Schuphan I, Hothorn LA, Gathmann A. Arthropods on maize ears for detecting impacts of Bt maize on nontarget organisms. Environmental entomology. 2006 Apr 1;35(2):554-560. doi: 10.1603/0046-225X-35.2.554
Gathmann A, Wirooks L, Hothorn LA, Bartsch D, Schuphan I. Impact of Bt maize pollen (MON810) on lepidopteran larvae living on accompanying weeds. Molecular ecology. 2006 Jun 7;15(9):2677-2685. doi: 10.1111/j.1365-294X.2006.02962.x
Hauschke D, Hothorn LA. An introductory note to the CHMP guidelines: Choice of the non-inferiority margin and data monitoring committees [1]. Statistics in medicine. 2006 Aug 10;26(1):230-233. doi: 10.1002/sim.2665
